$141.69
-2.68-1.86%
At close: Nov 13, 4:00 PM EST
$142.00
0.310.22%
After Hours: Nov 13, 6:12 PM EST
Axsome Therapeutics Inc
AXSMNASDAQ
The average analyst price target for Axsome Therapeutics is $235.38, 65.8% above the current price. Of 20 analysts, 20 rate it Buy. Targets range from $153 to $310. The latest change came on Nov 13, 2026, when Morgan Stanley lowered its price target on Axsome Therapeutics from $249 to $223 and kept an Equal-Weight rating.
Price Target Range — 8 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months
